Private Wealth Advisors (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$474K Buy
7,646
+1,059
+16% +$65.1K 0.27% 66
2020
Q3
$397K Sell
6,587
-261
-4% -$15.7K 0.25% 67
2020
Q2
$403K Hold
6,848
0.28% 64
2020
Q1
$413K Sell
6,848
-26
-0.4% -$1.59K 0.31% 61
2019
Q4
$446K Buy
+6,874
New +$394K 0.24% 86
2019
Q3
Sell
-5,229
Closed -$237K 136
2019
Q2
$237K Buy
5,229
+167
+3% +$7.78K 0.08% 131
2019
Q1
$242K Buy
5,062
+189
+4% +$9.41K 0.09% 123
2018
Q4
$253K Buy
4,873
+232
+5% +$12.5K 0.11% 118
2018
Q3
$288K Hold
4,641
0.11% 119
2018
Q2
$257K Sell
4,641
-200
-4% -$10.8K 0.1% 118
2018
Q1
$306K Sell
4,841
-75
-2% -$4.83K 0.12% 110
2017
Q4
$301K Hold
4,916
0.12% 114
2017
Q3
$313K Hold
4,916
0.13% 110
2017
Q2
$274K Buy
4,916
+699
+17% +$38K 0.12% 111
2017
Q1
$229K Buy
4,217
+360
+9% +$19.7K 0.1% 114
2016
Q4
$225K Buy
+3,857
New +$211K 0.1% 114

Other funds holding BMY

Private Wealth Advisors (Pennsylvania)'s BMY Position: Q4 2020 in Review

Private Wealth Advisors (Pennsylvania) increased its Bristol-Myers Squibb (BMY) stake by 16% in Q4 2020, buying an estimated $65.1K and bringing the position to 7,646 shares worth $474K. The position accounts for 0.27% of the portfolio, ranked #66.

Private Wealth Advisors (Pennsylvania) first reported a position in BMY in Q4 2016 and has held it in 16 quarters since. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Private Wealth Advisors (Pennsylvania) held 7,646 shares of Bristol-Myers Squibb worth $474K as of Q4 2020.
  • Private Wealth Advisors (Pennsylvania) bought 1,059 Bristol-Myers Squibb shares in Q4 2020, an estimated $65.1K.
  • Bristol-Myers Squibb made up 0.27% of Private Wealth Advisors (Pennsylvania)'s portfolio in Q4 2020, its #66 holding.
  • Private Wealth Advisors (Pennsylvania) first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 16 quarters since.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Private Wealth Advisors (Pennsylvania)'s 13F filing for Q4 2020, filed 9 Feb 2021.